Ind-Swift Laboratories Approves Corrigendum for Preferential Issue EGM
Ind-Swift Laboratories Limited confirmed that its internal committee approved a Corrigendum to the Extraordinary General Meeting (EGM) notice related to the proposed Preferential Issue of Fully Convertible Warrants. The decision followed the consideration of necessary modifications requested by stock exchanges concerning the Explanatory Statement for the upcoming meeting.The Committee, formed by the Board of Directors, reviewed and ratified the Corrigendum on Wednesday, July 29, 2026. This corrigendum pertains to the EGM scheduled to be held on Wednesday, August 05, 2026. The shareholders are being called to approve the proposed Preferential Issue of Fully Convertible Warrants through Video Conferencing (VC) or Other Audio-Visual Means (OAVM).
The modifications incorporated in the Corrigendum were required after receiving query letters from both the National Stock Exchange of India Limited and BSE Limited on July 20, 2026, and July 22, 2026, respectively. The Committee approved the revised notice incorporating these changes and authorized its subsequent circulation to members and submission to the stock exchanges.
The management confirmed that apart from the specific modifications detailed in the Corrigendum dated July 29, 2026, all other terms and conditions of the original Notice of EGM remain valid and unchanged.
Details of the Board Committee meeting are as follows:
| Activity | Date | Time |
|---|---|---|
| Meeting Commencement | July 29, 2026 | 04:45 P.M. |
| Meeting Conclusion | July 29, 2026 | 05:15 P.M. |
INDSWFTLAB Stock Price Movement
Shares of Ind-Swift Laboratories Limited slipped today by 4.37% to settle at ₹223.58 in post-market trading. The stock saw considerable volume, with 745,058 shares changing hands during the day's close.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.